Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.
Carballo-Diéguez A, Giguere R, .et al
AIDS Behav. 2017 Nov 8.
Abstrac

FULL-TEXT ARTICLE
HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis
Poteat T, Ackerman B, Diouf D, et al
PLoS Med. 2017 Nov 7;14
Paper

FULL-TEXT ARTICLE
Transgender women in Malaysia, in the context of HIV and Islam: a qualitative study of stakeholders' perceptions
Barmania S, Aljunid SM.
BMC Int Health Hum Rights. 2017 Oct 18;
Paper

Impact of Sexual Violence Across the Lifespan on HIV Risk Behaviors Among Transgender Women and Cisgender People Living With HIV.
Smith LR, Yore J, Triplett DP, et al
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):408-416.
Abstract

Acceptability of Daily Use of Free Oral Pre-exposure Prophylaxis (PrEP) Among Transgender Women Sex Workers in Shenyang, China.
Wang Z, Lau JTF, Yang X,  et al
AIDS Behav. 2017 Jul 27.
Abstract

FULL-TEXT ARTICLE
Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City.
Richardson S, Seekaew P, Koblin B, et al  P
LoS One. 2017 Jul 19;12(7):e0181702.
Paper

Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
Krakower DS, Ware NC, Maloney KM,
AIDS Patient Care STDS. 2017 Jun 2.
Abstract

Impact of Sexual Violence Across the Lifespan on HIV Risk Behaviors Among Transgender Women and Cisgender People Living With HIV.
Smith LR, Yore J, Triplett DP, et al
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):408-416.
Abstract

FULL-TEXT ARTICLE
HIV prevalence, risky behaviors, and discrimination experiences among transgender women in Cambodia: descriptive findings from a national integrated biological and behavioral survey
Yi S, Ngin C, Tuot S, et al 
BMC Int Health Hum Rights. 2017 May 23;17(1):14
Paper"

Factors Associated with Antiretroviral Therapy Adherence Among Transgender Women Receiving HIV Medical Care in the United States.
Mizuno Y, Beer L, Huang P, Frazier EL.
LGBT Health. 2017 May 12.
Abstract

HIV Prevalence, Sexual Partners, Sexual Behavior and HIV Acquisition Risk Among Trans Men, San Francisco, 2014.
McFarland W, Wilson EC, Raymond HF.
 AIDS Behav. 2017 Feb 24.  
Abstract

Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil.
Grinsztejn B, Jalil EM, Monteiro L, Velasque L, et al
Lancet HIV. 2017 Feb 7. 
Abstract

HIV in transgender women in Brazil.
Poteat T, Wirtz AL.
 Lancet HIV. 2017 Feb 7.
Abstract

Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis
Wood SM, Lee S, Barg FK,et al
J Adolesc Health. 2017 Jan 26.
Abstract

A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men.
Eaton LA, Matthews DD, Driffin DD,
Prev Sci. 2017 Jan 18.
Abstract

Comprehensive HIV Prevention for Transgender Persons.
Neumann MS, Finlayson TJ, Pitts NL, Keatley J.
Am J Public Health. 2016 Dec 20:e1-e6.
Abstract

HIV Diagnosis, Linkage to Care, and Retention among Men Who Have Sex with Men and Transgender Women in Guatemala City.
Barrington C, Knudston K, Bailey OA,  et al  J
 Health Care Poor Underserved. 2016;27(4):1745-1760.
Abstract

Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.
Siskind RL, Andrasik M, Karuna ST,  et al
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl
Abstract

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.
Anderson PL, Reirden D, Castillo-Mancilla J.
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S230-4
Abstract

Design Issues in Transgender Studies.
Hughes JP, Emel L, Hanscom B, Zangeneh S.
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S248-S251.
Abstract

Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.
Siskind RL, Andrasik M, Karuna ST, et al
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S243-S247.
Abstract

FULL-TEXT ARTICLE
Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women.
McGowan I, Cranston RD, Mayer KH et al
PLoS One. 2016 Jun 30;11(6):e0158310
Paper

Prevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Transgender Persons Referred to an Italian Center for Total Sex Reassignment Surgery.
Luzzati R, Zatta M, Pavan N, Serafin M, et al
Sex Transm Dis. 2016 Jul;43(7):407-11.
Abstract

HIV Status Communication with Sex Partners and Associated Factors Among High-Risk MSM and Transgender Women in Lima, Peru.
Konda KA, Castillo R, Leon SR, et al
AIDS Behav. 2016 Jun 4.
Abstract

Acceptability of Three Novel HIV Prevention Methods Among Young Male and Transgender Female Sex Workers in Puerto Rico.
Giguere R, Frasca T, Dolezal C, et al
AIDS Behav. 2016 Apr 5
Abstract

'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
Sevelius JM, Keatley J, Calma N, Arnold E.
Glob Public Health. 2016 Mar 10:1-16
Abstract

Comparison of Individual and Area Level Factors Between HIV-Infected Cisgender and Transgender Individuals in Florida (2006-2014).
Fennie KP, Trepka MJ, Maddox LM,  
AIDS Behav. 2016 Feb 17
Abstract

LifeSkills for Men (LS4M): Pilot Evaluation of a Gender-Affirmative HIV and STI Prevention Intervention for Young Adult Transgender Men Who Have Sex with Men.
Reisner SL, Hughto JM, Pardee DJ, et al  
J Urban Health. 2016 Jan 11.
Abstract

HIV Diagnoses and Care Among Transgender Persons and Comparison With Men Who Have Sex With Men: New York City, 2006-2011.
Wiewel EW, Torian LV, Merchant P, et al
 Am J Public Health. 2015 Dec 21:e1-e6.
Abstract

HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Deutsch MB, Glidden DV, Sevelius J, et al
Lancet HIV. 2015 Dec;2(12):e512-e519.
Abstract

Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study.
Lippman SA, Moran L, Sevelius J, et al
AIDS Behav. 2015 Oct 28.
Abstract

Risk Behavior and Sexually Transmitted Infections Among Transgender Women and Men Undergoing Community-Based Screening for Acute and Early HIV Infection in San Diego.
Green N, Hoenigl M, Morris S, Little SJ.
Medicine (Baltimore). 2015 Oct;94(41):e1830.
Abstract

"Just Because It's Out There, People Aren't Going to Use It." HIV Self-Testing Among Young, Black MSM, and Transgender Women.
Frye V, Wilton L, Hirshfied S, Chiasson MA,  et al
AIDS Patient Care STDS. 2015 Sep 16
Abstract

Risk factors associated with resistance to HIV testing among transwomen in Brazil.
Pinheiro Júnior FM, Kendall C, et al
AIDS Care. 2015 Aug 14:1-6.
Abstract

FULL-TEXT ARTICLE
Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges.
Veloso VG, Mesquita F, Grinsztejn B. et al
J Int AIDS Soc. 2015 Jul 20;18(4(Suppl 3)):20010.
Paper

HIV Testing by Transgender Status at Centers for Disease Control and Prevention-Funded Sites in the United States, Puerto Rico, and US Virgin Islands, 2009-2011.
Habarta N, Wang G, Mulatu MS, Larish N.
Am J Public Health. 2015 Jul 16:e1-e
Abstract

Feasibility and Acceptability of Developing a Multisite Clinical Cohort of Transgender People with HIV Infection.
Poteat TC, Hanna DB, Althoff KN.
AIDS Res Hum Retroviruses. 2015 Jun 30
Abstract

.FULL-TEXT ARTICLE
Knowledge, Indications and Willingness to Take Pre-Exposure Prophylaxis among Transwomen in San Francisco, 2013.
Wilson EC, Jin H, Liu A, Raymond HF.
PLoS One. 2015 Jun 3;10(6):e012897
Paper

Laboratory-confirmed HIV and sexually transmitted infection seropositivity and risk behavior among sexually active transgender patients at an adolescent and young adult urban community health center.
Reisner SL, Vetters R, White JM,  et al 
AIDS Care. 2015 Mar 19:1-6.
Abstract

Inclusion of trans women in pre-exposure prophylaxis trials: a review.
Escudero DJ, Kerr T, Operario D,  et al
AIDS Care. 2014 Nov 28:1-5.
Abstract

Population-Based HIV Prevalence and Associated Factors in Male-to-Female Transsexuals from Southern Brazil.
Costa AB, Fontanari AM, Jacinto MM, et al
Arch Sex Behav. 2014 Sep 23.
Abstract

Patterns and Correlates of PrEP Drug Detection among MSM and Transgender Women in the Global iPrEx Study.
Liu A, Glidden DV, Anderson PL,  et al
J Acquir Immune Defic Syndr. 2014 Sep 16
Abstract

Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
Grant RM, Anderson PL, McMahan V, et al
Lancet Infect Dis. 2014 Jul 22.

Abstract"
HIV risk and preventive interventions in transgender women sex workers.
Poteat T, Wirtz AL, Radix A, et al
Lancet. 2014 Jul 21.
Abstract

HIV Risk Behaviors in the U.S. Transgender Population: Prevalence and Predictors in a Large Internet Sample.
Feldman J, Romine RS, Bockting WO.
J Homosex. 2014 Jul 14||
Abstract

The Interaction of Drug Use, Sex Work, and HIV Among Transgender Women.
Hoffman BR.
Subst Use Misuse. 2014 Jul;49(8):1049-1053
Abstract

HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study.
Santos GM, Wilson EC, Rapues J,  et al
Sex Transm Infect. 2014 Apr 8.
Abstract

WHO guidelines for HIV/STI prevention and care among MSM and transgender people: implications for policy and practice
Cohen J, Lo YR, Caceres CF, et al
Sex Transm Infect 2013;89:536-538 
Commentary

FULL-TEXT ARTICLE
No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis.
Marcus JL, Glidden DV, Mayer KH,  et al
PLoS One. 2013 Dec 18;8(12):e81997.
Paper

HIV epidemics among transgender women.
Poteat T, Reisner SL, Radix A.
Curr Opin HIV AIDS. 2013 Dec 5
Abstract

Barriers and Facilitators to Engagement and Retention in Care among Transgender Women Living with Human Immunodeficiency Virus.
Sevelius JM, Patouhas E, Keatley JG, Johnson MO.
Ann Behav Med. 2013 Dec 7
Abstract

Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.
Baral SD, Poteat T, Strömdahl S,
Lancet Infect Dis. 2012 Dec 20.
Abstract

Community-based HIV prevention interventions that combat anti-gay stigma for men who have sex with men
and for transgender women.
Cahill S, Valadéz R, Ibarrola S.
J Public Health Policy. 2012 Nov 15.
Abstract

FULL-TEXT PDF ARTICLE
Using GRADE methodology for the development of public health guidelines for the prevention and treatment of
HIV and other STIs among men who have sex with men and transgender people.
Akl EA, Kennedy C, Konda K,  et al
BMC Public Health. 2012 May 28;12(1):386.
Paper